Proto Labs (PRLB) Tops Q4 EPS by 4c

Go back to Proto Labs (PRLB) Tops Q4 EPS by 4c

Benchmark Upgrades Proto Labs (PRLB) to Buy, '4Q22 Earnings, Forward Guidance Both Positive'

February 13, 2023 6:21 AM EST

Benchmark analyst Robert Wasserman upgraded Proto Labs (NYSE: PRLB) from Hold to Buy with a price target of $45.00.

THe analyst comments "Proto Labs reported better-than-expected financial results for their 4Q22, including revenues of $115.6 million, down 6.5% year-over-year, and nonGAAP earnings of $0.26 per share. Our estimates... More